It is the case of angiopietin-2 or osteoprotegerin that have been found to be good predictors of cardiovascular disease and subclinical atherosclerosis in patients with rheumatoid arthritis [25,26]. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.